After The Deluge, Hep C Players Look For Opportunity Submitted by admin on Thu, 11/17/2016 - 09:57 Read more about After The Deluge, Hep C Players Look For Opportunity Source Seeking Alpha Headline After The Deluge, Hep C Players Look For Opportunity News Tags hepatitis C Gilead Sciences AbbVie Epclusa glecaprevir/pibrentasvir sofosbuvir/velpatasvir
3 Potential Blockbuster Drugs Launching in 2016 Submitted by admin on Wed, 01/06/2016 - 10:57 Read more about 3 Potential Blockbuster Drugs Launching in 2016 Source Investors.com Headline 3 Potential Blockbuster Drugs Launching in 2016 News Tags Merck hepatitis C elbasvir/grazoprevir Gilead Sciences sofosbuvir/velpatasvir Eli Lilly psoriasis ixekizumab